Drug-labels.com

Prepidil Gel: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Post Market
Strength:
0.5 mg
Active ingredient:

Patient Medication Information: uses, side effects, how to take - Prepidil Gel

ABOUT THIS MEDICATION

What the medication is used for:

PREPIDIL gel is used to start the “cervical softening” and dilation of the cervix in pregnant women at the end of pregnancy.

What it does:

PREPIDIL gel is an oxytocic agent, its effect on uterine smooth muscle leads to the cervix ripening (opening of the uterus) and results in labour induction.

When it should not be used:

PREPIDIL gel should not be used if:

  • You cannot be given Oxytocic drugs or unable to have

    prolonged contractions of the uterus;

  • You have ruptured amniotic membranes or

    choriamnionitis (inflammation of the fetal membranes)

  • You have unexplained vaginal bleeding during

    pregnancy;

  • You are unable to have vaginal delivery;
  • When drugs used to stimulate labour are not required or

    when prolonged contraction of the uterus may be harmful to the baby’s safety or stability of the uterus

  • You are allergic to prostaglandins or any other oxytocic

    drug or any of the other ingredients in PREPIDIL Gel;

  • You have no engagement of the baby head (baby's head

    down into the pelvis), or abnormal position of the placenta or umbilical cord; or fetal malpresentation (baby in the difficult position for the birth process);

  • You have or have had untreated pelvic inflammatory

    disease;

  • You are having heart, lung, kidney, or liver disease;

    PREPIDIL gel should not be used together with other oxytocics.

What the medicinal ingredient is:

Dinoprostone (PGE2)

What the important nonmedicinal ingredients are:

Colloidal silicon, dioxide and triacetin

What dosage forms it comes in:

PREPIDIL is supplied as a translucent sterile gel preparation in a prefilled syringe with an accompanying catheter.

Each syringe contains:

0.5 mg dinoprostone (PGE2)/2.5 mL Syringe (3 g)

WARNINGS AND PRECAUTIONS

PREPIDIL should be given to you by doctor experienced in using this drug.

PREPIDIL gel may cause uterine rupture and/or cervical laceration (tearing), and anaphylactoid syndrome of Pregnancy (amniotic fluid embolism).

BEFORE you use PREPIDIL gel talk to your doctor if:

  • You are 35 years of age and over with complications during pregnancy;
  • You have had blood clotting problem after giving birth

    (post-partum);

  • You have or have had seizure;
  • You have asthma or glaucoma;
  • You have heart, liver, kidney problem;

INTERACTIONS WITH THIS MEDICATION

Before receiving PREPIDIL gel, tell your doctor if you are taking other drugs, including non-prescription and natural health products.

PROPER USE OF THIS MEDICATION

Usual dose:

The recommended dose of PREPIDIL (dinoprostone gel) is 0.5 mg equivalent to the use of one prefilled syringe. Each syringe is intended for single dose administration.

After you doctor has placed the gel, you should remain lying on your back for 10-15 minutes to minimize gel leakage.

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

Missed Dose:

N/A

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Possible side effects on mother (10%), including uterine contractile abnormalities without fetal heart change (5%), IMPORTANT: PLEASE READ

PREPIDIL Gel (dinoprostone) Product Monograph Page 28 of 28 vomiting and diarrhea (5%), fever (>1%), back pain (>1%),

warm feeling in vagina (>1%).

Possible side effects on baby (16%), including fetal heart rate

change and unclassified fetal distress (13%), uterine contractile

abnormalities with fetal heart change (3%), and depressed

neonates (13 % at 1 minute):

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effect

Talk with your

doctor or pharmacist

Stop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Common

Abnormal

labour

affecting fetus

Fetal distress syndrome

Uterine

hypertonus

T

T

T

UncommonNausea, vomiting, diarrheaTT

This is not a complete list of side effects. For any unexpected effects while taking PREPIDIL Gel, contact your doctor or pharmacist.

HOW TO STORE IT

Store in a refrigerator at a temperature lower than 4°C

REPORTING SUSPECTED SIDE EFFECTS

You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following 3 ways:

-------------------------------------------------------------------------- $ Report online at www.healthcanada.gc.ca/medeffect $ Call toll-free at 1-866-234-2345

$ Complete a Canada Vigilance Reporting Form and:

  • Fax toll-free to 1-866-678-6789, or
  • Mail to: Canada Vigilance Program Health Canada

    Postal Locator 0701D

    Ottawa, Ontario

    K1A 0K9

Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at www.healthcanada.gc.ca/medeffect.

NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

Last revised: September 05, 2012

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 00860786

Revision date stated in the text: September 5, 2012

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Prepidil Gel

Rx or OTC
Prescription (Rx)?
DIN 00860786
Schedule(s) PRESCRIPTION
Active ingredient(s) Dinoprostone 0.5 MG
Dosage form(s) Gel
Route(s) of administration Intracervical
Drug class (WHO ATC)
  1. G Genito urinary system and sex hormones
    1. G02 Other gynecologicals
      1. G02A Uterotonics
        1. G02AD Prostaglandins, oxytocics
          1. G02AD02 Dinoprostone
Company PFIZER CANADA ULC
Current status Cancelled Post Market
Current status date July 29, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.